Another Take on Personalized Medicine Investment Opportunities

A very sharp research analyst and an old friend, John Putman, has landed at Next Wave Research, and is up to his old tricks of ferreting out good ideas in the smallcap medtech universe.  His blog entry of March 2 has highlighted some personalized medicine ideas and I think it is worth reading and considering.  John’s post mentions Clarient, Inc.  (Nasdaq:CLRT) (, Combimatrix (Nasdaq:CBMX) (, Rosetta Genomics (Nasdaq:ROSG) (, VirtualScopics (Nasdaq:VSCP) ( and Orasure, Inc. (Nasdaq:OSUR) (

Here is the link to the post:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s